AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹99 Cr | ₹121 Cr | ₹102 Cr | ₹103 Cr | ₹105 Cr |
What is the latest Total Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹99 Cr |
| Mar2025 | ₹121 Cr |
| Mar2024 | ₹102 Cr |
| Mar2023 | ₹103 Cr |
| Mar2022 | ₹105 Cr |
How is Total Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹99 Cr | -18.23 | |
| Mar2025 | ₹121 Cr | 17.78 | |
| Mar2024 | ₹102 Cr | -0.54 | |
| Mar2023 | ₹103 Cr | -2.46 | |
| Mar2022 | ₹105 Cr | - | |
Compare Total Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹236.6 Cr | -5.5% | -4.6% | -11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -5.5% |
-4.6% |
-11.5% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses